AMRX
Price
$7.26
Change
-$0.16 (-2.16%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
1.87B
78 days until earnings call
LFCR
Price
$6.45
Change
-$0.18 (-2.71%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
176.87M
98 days until earnings call
Interact to see
Advertisement

AMRX vs LFCR

Header iconAMRX vs LFCR Comparison
Open Charts AMRX vs LFCRBanner chart's image
Amneal Pharmaceuticals
Price$7.26
Change-$0.16 (-2.16%)
Volume$31.63K
Capitalization1.87B
Lifecore Biomedical
Price$6.45
Change-$0.18 (-2.71%)
Volume$1.41K
Capitalization176.87M
AMRX vs LFCR Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. LFCR commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and LFCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (AMRX: $7.27 vs. LFCR: $6.45)
Brand notoriety: AMRX and LFCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 99% vs. LFCR: 56%
Market capitalization -- AMRX: $1.87B vs. LFCR: $176.87M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. LFCR’s [@Pharmaceuticals: Other] market capitalization is $176.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, LFCR is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while LFCR’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • LFCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AMRX and LFCR are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -1.09% price change this week, while LFCR (@Pharmaceuticals: Other) price change was -3.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.61%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +28.86%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

LFCR is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than LFCR($177M). AMRX YTD gains are higher at: -8.207 vs. LFCR (-13.190). AMRX has higher annual earnings (EBITDA): 400M vs. LFCR (-22.64M). AMRX has more cash in the bank: 91.5M vs. LFCR (4.22M). LFCR has less debt than AMRX: LFCR (157M) vs AMRX (2.75B). AMRX has higher revenues than LFCR: AMRX (2.39B) vs LFCR (188M).
AMRXLFCRAMRX / LFCR
Capitalization1.87B177M1,056%
EBITDA400M-22.64M-1,767%
Gain YTD-8.207-13.19062%
P/E Ratio90.00N/A-
Revenue2.39B188M1,273%
Total Cash91.5M4.22M2,167%
Total Debt2.75B157M1,752%
FUNDAMENTALS RATINGS
AMRX vs LFCR: Fundamental Ratings
AMRX
LFCR
OUTLOOK RATING
1..100
7277
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
52100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
5750
P/E GROWTH RATING
1..100
244
SEASONALITY SCORE
1..100
1685

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRX's Valuation (92) in the Pharmaceuticals Major industry is in the same range as LFCR (93) in the Industrial Specialties industry. This means that AMRX’s stock grew similarly to LFCR’s over the last 12 months.

AMRX's Profit vs Risk Rating (52) in the Pharmaceuticals Major industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that AMRX’s stock grew somewhat faster than LFCR’s over the last 12 months.

AMRX's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as LFCR (99) in the Industrial Specialties industry. This means that AMRX’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (50) in the Industrial Specialties industry is in the same range as AMRX (57) in the Pharmaceuticals Major industry. This means that LFCR’s stock grew similarly to AMRX’s over the last 12 months.

LFCR's P/E Growth Rating (4) in the Industrial Specialties industry is in the same range as AMRX (24) in the Pharmaceuticals Major industry. This means that LFCR’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXLFCR
RSI
ODDS (%)
Bullish Trend 7 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLMFX9.18N/A
N/A
Meeder Muirfield Retail
JUECX23.27N/A
N/A
JPMorgan US Equity C
ALVSX10.49N/A
N/A
American Century Focused Lg Cap Val I
DNDGX19.21N/A
N/A
Dunham Small Cap Growth N
GSBDX15.04N/A
N/A
Goldman Sachs Small Cap Growth A

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-2.02%
PAHC - AMRX
44%
Loosely correlated
-3.49%
HROW - AMRX
41%
Loosely correlated
-4.77%
VTRS - AMRX
38%
Loosely correlated
-4.50%
TEVA - AMRX
38%
Loosely correlated
-1.37%
ZTS - AMRX
37%
Loosely correlated
-1.35%
More

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-2.71%
SHPH - LFCR
31%
Poorly correlated
-7.23%
ALKS - LFCR
27%
Poorly correlated
-3.60%
AMRX - LFCR
27%
Poorly correlated
-2.02%
OGI - LFCR
27%
Poorly correlated
-0.74%
TLRY - LFCR
27%
Poorly correlated
-4.42%
More